We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Sclerosis treatment drugs.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Sclerosis treatment drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Sclerosis treatment drugs Product List

1～6 item / All 6 items

Displayed results
[Research Materials] Global Market for Atherosclerosis Treatment Drugs

[Research Materials] Global Market for Atherosclerosis Treatment Drugs

World Market for Atherosclerosis Treatment Drugs: Internal Medicine, Surgery, Hospitals, Clinics, Others

This research report (Global Arteriosclerosis Therapeutics Market) investigates and analyzes the current state and future outlook of the global market for arteriosclerosis therapeutics over the next five years. It includes information on the overview of the global arteriosclerosis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on internal medicine and surgery, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for arteriosclerosis therapeutics. It also includes the market share of major companies in the arteriosclerosis therapeutics sector, product and business overviews, and sales performance.

  • Other services
  • Sclerosis treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Multiple Sclerosis Drug Treatment

[Research Material] Global Market for Multiple Sclerosis Drug Treatment

Global Market for Multiple Sclerosis Drug Treatment: Interferons, Immunomodulators, Immunosuppressants, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

This research report (Global Multiple Sclerosis Drugs Treatment Market) investigates and analyzes the current status and outlook for the global market for multiple sclerosis drug treatment over the next five years. It includes information on the overview of the global multiple sclerosis drug treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include interferons, immunomodulators, and immunosuppressants, while the segments by application focus on hospital pharmacies, retail pharmacies, online pharmacies, and others. The regional segments calculate the market size for multiple sclerosis drug treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the multiple sclerosis drug treatment sector, product and business overviews, and sales performance.

  • Other services
  • Sclerosis treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Primary Progressive Multiple Sclerosis Treatment

[Research Material] Global Market for Primary Progressive Multiple Sclerosis Treatment

World Market for One-Time Treatment of Multiple Sclerosis: ApE, Biotin, GZ-402668, Ibudilast, Idebenone, Lakininomod Sodium ...

This research report (Global Primary Progressive Multiple Sclerosis Treatment) investigates and analyzes the current status and outlook for the global market for primary progressive multiple sclerosis treatment over the next five years. It includes information on the global overview of the primary progressive multiple sclerosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the primary progressive multiple sclerosis treatment market by type include ApE, biotin, GZ-402668, ibudilast, idebenone, lacosamide sodium, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for primary progressive multiple sclerosis treatment. It also includes the market share of major companies in the primary progressive multiple sclerosis treatment sector, product and business overviews, and sales performance.

  • Other services
  • Sclerosis treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
The global market for the treatment of amyotrophic lateral sclerosis (ALS).

The global market for the treatment of amyotrophic lateral sclerosis (ALS).

Global Market for Amyotrophic Lateral Sclerosis (ALS) Treatment: Chemotherapy, Stem Cell Therapy, Hospitals, Diagnostic Centers, Clinics, Retail Pharmacies

This research report (Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease)) investigates and analyzes the current state and future outlook of the global market for amyotrophic lateral sclerosis (ALS) treatment over the next five years. It includes information on the overview of the global ALS treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the ALS treatment market by type focus on chemotherapy and stem cell therapy, while the segments by application target hospitals, diagnostic centers, clinics, and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for ALS treatment. It also includes the market share of major companies in the ALS treatment sector, product and business overviews, and sales performance.

  • Other services
  • Sclerosis treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Progressive Relapsing Multiple Sclerosis

[Research Material] Global Market for Treatment of Progressive Relapsing Multiple Sclerosis

Global Market for Treatment of Progressive Relapsing Multiple Sclerosis: COG-133, GZ-402668, Inebilizumab, VCE-0032, Others, etc.

This research report (Global Progressive Relapsing Multiple Sclerosis Tr) investigates and analyzes the current state and outlook for the global market for progressive relapsing multiple sclerosis treatment over the next five years. It includes information on the overview of the global progressive relapsing multiple sclerosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the progressive relapsing multiple sclerosis treatment market include COG-133, GZ-402668, Inebilizumab, VCE-0032, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for progressive relapsing multiple sclerosis treatment. It also includes the market share of major companies in progressive relapsing multiple sclerosis treatment, product and business overviews, and sales performance.

  • Other services
  • Sclerosis treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Secondary Progressive Multiple Sclerosis

[Research Material] Global Market for Treatment of Secondary Progressive Multiple Sclerosis

World Market for Treatment of Secondary Progressive Multiple Sclerosis: Inebilizumab, GLX-1112, DC-TAB, Etomoxir, IB-MS, and others...

This research report (Global Secondary Progressive Multiple Sclerosis Drug Market) investigates and analyzes the current state and outlook for the global market of secondary progressive multiple sclerosis treatment drugs over the next five years. It includes information on the overview of the global secondary progressive multiple sclerosis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Inebilizumab, GLX-1112, DC-TAB, Etomoxir, IB-MS, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for secondary progressive multiple sclerosis treatment drugs. It also includes the market share of major companies in the secondary progressive multiple sclerosis treatment drug market, product and business overviews, and sales performance.

  • Other services
  • Sclerosis treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Sclerosis treatment drugs

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.